Source:http://linkedlifedata.com/resource/pubmed/id/15239126
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2004-7-7
|
pubmed:abstractText |
The SET-CAN fusion gene is the product of a chromosomal rearrangement found on 9q34 associated with an acute undifferentiated leukemia. SET-CAN encodes an almost complete SET protein fused to the C-terminal two-thirds of CAN. SET is also known as TAF-Ibeta, a histone chaperone and intracellular inhibitor of protein phosphatase 2A, whereas CAN is identical to Nup214, a nucleoporin protein. To obtain insight into the leukemogenic function of SET/TAF-Ibeta-CAN/Nup214, we have examined its subcellular localization. Immunofluorescence analyses showed that SET/TAF-Ibeta and CAN/Nup214 are found in the nucleus and the nuclear envelope, respectively, whereas the majority of SET/TAF-Ibeta-CAN/Nup214 is localized in the nucleus. SET/TAF-Ibeta-CAN/Nup214 interacted with hCRM1, one of the nuclear export factors, and caused aberrant intracellular localization of hCRM1. In cells expressing SET/TAF-Ibeta-CAN/Nup214, a protein containing a nuclear export signal accumulated in the nucleus. The export of this protein was partially restored by overexpression of hCRM1. These results suggest that aberrantly localized molecules associated with SET/TAF-Ibeta-CAN/Nup214 may be involved in oncogenesis.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0020-7136
|
pubmed:author | |
pubmed:copyrightInfo |
Copyright 2004 Wiley-Liss, Inc.
|
pubmed:issnType |
Print
|
pubmed:day |
10
|
pubmed:volume |
111
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
501-7
|
pubmed:dateRevised |
2007-7-24
|
pubmed:meshHeading |
pubmed-meshheading:15239126-Active Transport, Cell Nucleus,
pubmed-meshheading:15239126-Cell Nucleus,
pubmed-meshheading:15239126-Cell Transformation, Neoplastic,
pubmed-meshheading:15239126-Fluorescent Antibody Technique,
pubmed-meshheading:15239126-HeLa Cells,
pubmed-meshheading:15239126-Humans,
pubmed-meshheading:15239126-Leukemia,
pubmed-meshheading:15239126-Oncogene Proteins, Fusion,
pubmed-meshheading:15239126-Plasmids,
pubmed-meshheading:15239126-Precipitin Tests,
pubmed-meshheading:15239126-Reverse Transcriptase Polymerase Chain Reaction
|
pubmed:year |
2004
|
pubmed:articleTitle |
Aberrant intracellular localization of SET-CAN fusion protein, associated with a leukemia, disorganizes nuclear export.
|
pubmed:affiliation |
Department of Infection Biology, Institute of Basic Medical Sciences, University of Tsukuba, Tsukuba, Japan.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|